Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MODAFINIL vs MOGAMULIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MODAFINIL vs MOGAMULIZUMAB: Safety Overview

Metric MODAFINIL MOGAMULIZUMAB
Total FAERS Reports 3,375 441
Deaths Reported 157 128
Death Rate 4.7% 29.0%
Hospitalizations 556 181
Average Patient Age 44.4 yrs 64.5 yrs
% Female Patients 62.0% 38.1%
FDA Approval Date Aug 16, 2017 N/A
Manufacturer Alembic Pharmaceuticals Limited Kyowa Kirin, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription N/A